To the surprise of medical researchers, a major new study has found no benefit -- and perhaps even some harm -- from adding the anti-clotting drug Plavix to aspirin in an attempt to prevent heart ...

Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.

Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke prevention in people with a history of lacunar strokes, and the combination carries a greater risk of ...

Which patients should be on a regimen of aspirin or clopidogrel (Plavix)? What role does warfarin (Coumadin) play in those requiring anticoagulation therapy? —Jill Schmidt, PA-C, Belmont, Mich.

Please provide your email address to receive an email when new articles are posted on . After a minor stroke or transient ischemic attack, patients with normal vs. impaired renal function treated with ...

ORLANDO, Florida (Reuters) - Aspirin alone proved as effective as aspirin plus the blood clot preventer Plavix in keeping coronary artery bypass grafts open during the first year after surgery, ...

People at high risk for recurrent cardiac events following percutaneous coronary intervention (PCI), a procedure to open blocked arteries, experienced significantly better outcomes with clopidogrel ...

The INSPIRES, a double-blind, placebo-controlled trial, involved patients with mild ischemic stroke or high-risk TIA of presumed atherosclerotic cause who had not undergone thrombolysis or ...

CHICAGO -- For prolonged antithrombotic treatment after percutaneous coronary intervention (PCI), clopidogrel monotherapy was more effective and at least as safe as aspirin monotherapy in a high-risk ...

Mar. 31 -- TUESDAY, March 31 (HealthDay News) -- Combining the clot-preventing drug Plavix with aspirin is an effective substitute treatment for people at high risk of stroke and heart attack because ...

A P2Y12 inhibitor, such as clopidogrel or ticagrelor, might be a better choice than aspirin for antiplatelet monotherapy in patients with coronary artery disease, results of a new meta-analysis ...